0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Optimal Treatment of Chronic Obstructive Pulmonary Disease: The Search for the Magic Combination of Inhaled Bronchodilators and Corticosteroids

Gerard J. Criner, MD
[+] Article and Author Information

From Temple University School of Medicine, Philadelphia, Pennsylvania.


Potential Financial Conflicts of Interest: Consultancies: Ortho Biotech, Schering-Plough, Boehringer Ingelheim, Actelion, Shire Pharmaceuticals, Sepracor Pharmaceuticals; Honoraria: Ortho Biotech, Schering-Plough, Boehringer Ingelheim, Actelion, Shire Pharmaceuticals, Sepracor Pharmaceuticals; Grants received: Schering-Plough, Boehringer Ingelheim, Actelion, GlaxoSmithKline, Altana Pharma, Daiichi Asubio Pharmaceuticals, Pfizer Inc., Roche Pharmaceuticals, Sepracor Pharmaceuticals, Emphasys Medical Inc., Aeris Therapeutics Inc.; Grants pending: Boehringer Ingelheim, GlaxoSmithKline.

Requests for Single Reprints: Gerard J. Criner, MD, Pulmonary and Critical Care Medicine and Temple Lung Center, Temple University School of Medicine, 745 Parkinson Pavilion, 3401 North Broad Street, Philadelphia, PA 19140; e-mail, crinerg@tuhs.temple.edu.


Ann Intern Med. 2007;146(8):606-608. doi:10.7326/0003-4819-146-8-200704170-00012
Text Size: A A A

Chronic obstructive pulmonary disease (COPD) is an international disease: Not only does it affect 10 to 24 million adults in the United States (1), but it is also the fourth leading cause of death in both the United States and the world (2). The global burden of COPD will increase dramatically in the coming years (3). A recent assessment by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) projects that COPD will be the fifth leading cause of disease worldwide and the third leading cause of death by 2020 (3).

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)